SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Stock Picking for Charity - 2004 -- Ignore unavailable to you. Want to Upgrade?


To: rkrw who wrote (87)1/7/2004 10:02:51 AM
From: Arthur Radley  Respond to of 346
 
8:54AM CSFB names biotech top picks : CSFB remains Overweight the biotech sector entering 2004, and advises a mid-cap and small-cap focus, where they believe exciting values exist. In addition to naming RIGL as their top small-cap pick (see 8:18 comment), they name MICU as their top new product launch idea and add the stock to their Focus List, name MYOG as their top Phase III data story, TELK as their top cancer stock, and AMGN and GILD as their top large-cap stock ideas.



To: rkrw who wrote (87)1/7/2004 10:16:42 AM
From: scaram(o)uche  Respond to of 346
 
quick 3X thus far, but subject to lock-up fears which need to be motored over........

Message 19623239

for soy freaks.



To: rkrw who wrote (87)1/7/2004 11:01:18 AM
From: Biomaven  Respond to of 346
 
what an MSHL is

Spin-off of Novagen's cancer drug. NVGN owns 90% of the shares, so it's very thinly traded. Rick was smart enough to go for the warrants - I just have the stock. Very speculative - just right for this competition. <g>

We discusssed it a while back on the Valuation thread:

Message 18907352

Peter